Latest News on AHA/ACC Primary Prevention Guidelines

Most cardiovascular diseases and mortality come down to 4 years of unhealthy habits (smoking, poor diet, obesity and sedentarism) and 3 major risk factors (cholesterol, hypertension, and diabetes). 

Novedades en las guías de prevención primaria de la AHA/ACC

Ideal cardiovascular health, defined as absence or control of these 7 factors, is far less frequent than we might believe. It is estimated that 87% of the middle-aged adult population and 95% of people over 60, present at least 4 of these factors.

Recommendations on the calculated risk for decision making when it comes to hypertension and hypercholesterolemia have not seen changes recently. 

In other points, new evidence has been incorporated to the new guidelines. 

  • Aspirin: the prophylactic use of aspirin has been put into question. The new guidelines explicitly warn against the risk in patients over 70 and in patients with increased bleeding risk (prior bleeding, coagulopathy, thrombocytopenia, kidney failure or concomitant use of drugs that will increase bleeding). 

Read also: New Valvular Heart Disease Guidelines with Key TAVI and Mitral Regurgitation Updates.


Aspirin indication as primary prevention in middle aged adults is now a IIB recommendation.

  • Smoking: though significantly reduced, it is estimated 35% of men and 20% of women still smoke. Guidelines insist on the importance of routine questions about smoking habits and strongly advice against it (including vaping). 
  • Nutrition, diet, overweight, and obesity: guidelines recommend higher consumption of vegetables, fruit, legumes, nuts, whole grains, and fish. They also advice against processed meats, refined carbohydrates, and sweet drinks. 
  • Exercise and physical activity: asking about the level of physical activity and advising on optimal levels should be routine.  Guidelines recommend 150 minutes a week of intense to moderate activity, 75 minutes of intense activity or a combination of both. For sedentary patients, any kind of physical activity is better than nothing. 
  • Diabetes: one in every three adults meets the criteria for a prediabetic condition and approximately 10% has been diagnosed with type 2 diabetes. Diet, physical activity and weight control are critical to the development and progress of diabetes. 

Read also: Optimal Medical Treatment Under-used in Vascular Peripheral Disease.


For patients who have been diagnosed, metformin is the first line of treatment, with a IIa indication. Sodium/glucose 2 cotransporter Inhibitors and glucagon antagonists are reserved for diabetic patients and additional risk factors. (class IIb).

Conclusion

The new primary prevention guidelines summarize recommendations for the correct identification and modification of risk factors. Creating multidisciplinary teams to implement these guidelines and committing patients to become our life-long allies in this process depends entirely on us. 

Original Title: The New 2019 AHA/ACC Guideline on the Primary Prevention of Cardiovascular Disease.

Reference: Vera Bittner. Circulation. 2020;142:2402–2404. DOI: 10.1161/CIRCULATIONAHA.119.040625.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | P2Y12 Inhibitor Monotherapy After Complex PCI in ACS: Results From the NEO-MINDSET COMPLEX Subanalysis

This is a summary of the NEO-MINDSET COMPLEX subanalysis, presented by Dr. Guy Prado at EuroPCR 2026, which evaluated P2Y12 inhibitor monotherapy versus dual...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Inflammation after TAVI: An Emerging Therapeutic Target?

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...